Get the Stockscreener App
3.82
1.80%
-0.07
After Hours:
3.82
Genenta Science Spa Adr Stock (GNTA) Forecast
The Genenta Science Spa Adr (GNTA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6825, representing a -82.13% decrease from the current price of $3.82. The highest analyst price target is $0.4706, and the lowest is $0.8944.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GNTA Price Target
Average 1.3873
(-63.68% Downside)
Is Genenta Science Spa Adr (GNTA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.08 | Neutral |
| STOCH(9,6) | 23.34 | Neutral |
| STOCHRSI(14) | 20.84 | Neutral |
| MACD(12,26) | -0.1039 | Buy |
| ADX(14) | 18.75 | Neutral |
| William %R | -79.05 | Neutral |
| CCI(14) | -66.75 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.9339
Sell
|
3.9183
Sell
|
| MA20 |
3.9124
Sell
|
3.9753
Sell
|
| MA50 |
4.3474
Sell
|
4.2363
Sell
|
| MA100 |
4.7435
Sell
|
4.3913
Sell
|
| MA200 |
4.2158
Sell
|
4.406
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GNTA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on GNTA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.08 indicates that GNTA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.34 indicates that GNTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.84 indicates that GNTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.75 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.75 indicates that GNTA is still oversold but not to an extreme extent.
Long-term GNTA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Genenta Science Spa Adr financial reports and earnings history, Genenta Science Spa Adr (GNTA) stock could reach $12.76 by 2030, $12.60 by 2040 and $33.12 by 2050. See the projected annual prices until 2050 of the Genenta Science Spa Adr stock below:
- Genenta Science Spa Adr (GNTA) is expected to reach an average price of $25.07 in 2035, with a high prediction of $25.72 and a low estimate of $25.01. This indicates an $556.26% rise from the last recorded price of $3.82.
- Genenta Science Spa Adr (GNTA) stock is projected to chart a bullish course in 2040, with an average price target of $11.79, representing an $208.56% surge from its current level. The forecast ranges from a conservative $12.83 to a sky-high $12.60.
- Our analysts predict Genenta Science Spa Adr (GNTA) to jump 444.32% by 2045, soaring from $21.18 to an average price of $20.79, potentially reaching $21.32. While $21.18 is the low estimate, the potential upside is significant.
- Genenta Science Spa Adr (GNTA) stock is expected to climb by 2050, reaching an average of $33.14, a $767.55% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.12 and $33.20, respectively, highlighting the market's uncertainty.
Genenta Science Spa Adr Stock (GNTA) Year by Year Forecast
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2025
Genenta Science Spa Adr Stock (GNTA) is expected to reach an average price of $1.3873 in 2025, with a high prediction of $2.7572 and a low estimate of $0.0173. This indicates an -63.68% fall from the last recorded price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.6706 | $0.8944 | $0.4706 | -82.44% |
| April, 2025 | $0.6193 | $0.7855 | $0.7258 | -83.79% |
| May, 2025 | $0.4833 | $0.1003 | $0.9035 | -87.35% |
| June, 2025 | $0.7837 | $0.0173 | $1.0387 | -79.49% |
| July, 2025 | $1.1876 | $0.77 | $1.7976 | -68.91% |
| August, 2025 | $1.8728 | $1.2714 | $2.3052 | -50.97% |
| September, 2025 | $1.3679 | $1.2679 | $2.5241 | -64.19% |
| October, 2025 | $1.6769 | $1.0869 | $2.3931 | -56.10% |
| November, 2025 | $1.8274 | $1.2107 | $2.5021 | -52.16% |
| December, 2025 | $1.951 | $0.6634 | $2.7572 | -48.93% |
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2026
The predicted value for Genenta Science Spa Adr (GNTA) in 2026 is set at an average of $1.284. Estimates vary from a peak of $2.4386 to a trough of $0.1294, indicating an -66.39% surge from the present price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0862 | $1.3148 | $2.4386 | -45.39% |
| February, 2026 | $1.9513 | $1.453 | $2.3413 | -48.92% |
| March, 2026 | $1.8965 | $1.2851 | $2.2527 | -50.35% |
| April, 2026 | $1.5555 | $1.2555 | $2.3441 | -59.28% |
| May, 2026 | $2.0306 | $1.5392 | $2.3872 | -46.84% |
| June, 2026 | $1.7658 | $1.1158 | $2.3258 | -53.78% |
| July, 2026 | $1.9454 | $1.4147 | $2.2109 | -49.07% |
| August, 2026 | $1.3899 | $1.2299 | $2.1245 | -63.62% |
| September, 2026 | $1.7189 | $0.3751 | $1.7189 | -55.00% |
| October, 2026 | $1.406 | $1.2326 | $2.2326 | -63.19% |
| November, 2026 | $0.8526 | $0.7292 | $1.8578 | -77.68% |
| December, 2026 | $0.8838 | $0.1294 | $1.6382 | -76.86% |
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Genenta Science Spa Adr (GNTA) is $5.4036, with a high forecast of $6.4747 and a low forecast of $4.3324. This indicates an +41.46% increase from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.246 | $4.3324 | $5.246 | +37.33% |
| February, 2027 | $6.9869 | $5.3121 | $5.2169 | +82.90% |
| March, 2027 | $6.039 | $6.579 | $6.4747 | +58.09% |
| April, 2027 | $6.3287 | $6.3069 | $6.2587 | +65.67% |
| May, 2027 | $6.5184 | $6.7511 | $6.4435 | +70.64% |
| June, 2027 | $4.9655 | $4.5856 | $5.7808 | +29.99% |
| July, 2027 | $4.5765 | $5.0953 | $4.5765 | +19.80% |
| August, 2027 | $5.0498 | $5.0325 | $4.9474 | +32.19% |
| September, 2027 | $5.3619 | $5.1846 | $5.3619 | +40.36% |
| October, 2027 | $6.1516 | $6.3143 | $5.5967 | +61.04% |
| November, 2027 | $6.0412 | $6.2912 | $5.844 | +58.15% |
| December, 2027 | $5.8209 | $6.0209 | $6.0289 | +52.38% |
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2028
In 2028, Genenta Science Spa Adr (GNTA) is projected to reach an average price of $3.2926, with a high projection of $5.1858 and a low estimate of $1.3995. This indicates an -13.81% fall from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.5832 | $5.2006 | $5.1858 | +19.98% |
| February, 2028 | $4.1477 | $4.5303 | $4.3254 | +8.58% |
| March, 2028 | $3.5748 | $3.5748 | $3.5599 | -6.42% |
| April, 2028 | $2.7544 | $2.8896 | $2.7872 | -27.89% |
| May, 2028 | $3.1665 | $2.4893 | $2.8166 | -17.11% |
| June, 2028 | $2.6462 | $2.4814 | $2.549 | -30.73% |
| July, 2028 | $2.3606 | $2.811 | $2.3786 | -38.20% |
| August, 2028 | $2.068 | $2.2062 | $2.3431 | -45.86% |
| September, 2028 | $1.7976 | $2.1476 | $1.9704 | -52.94% |
| October, 2028 | $1.7973 | $1.7973 | $2.0025 | -52.95% |
| November, 2028 | $1.3995 | $1.3995 | $1.8973 | -63.36% |
| December, 2028 | $1.8891 | $1.6118 | $1.3892 | -50.55% |
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2029
The 2029 price forecast for Genenta Science Spa Adr Stock (GNTA) is $7.0513 on average, with a high prediction of $13.13 and a low estimate of $0.9733. This represents an +84.59% increase from the previous price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1395 | $1.5312 | $1.2603 | -70.17% |
| February, 2029 | $1.0809 | $1.3809 | $1.0309 | -71.71% |
| March, 2029 | $1.0598 | $0.9733 | $0.9733 | -72.26% |
| April, 2029 | $1.4802 | $1.3484 | $1.1907 | -61.25% |
| May, 2029 | $0.9823 | $1.6626 | $1.5275 | -74.29% |
| June, 2029 | $1.16 | $1.0995 | $0.9795 | -69.63% |
| July, 2029 | $1.5782 | $1.1123 | $1.2516 | -58.68% |
| August, 2029 | $1.265 | $1.2387 | $1.2913 | -66.88% |
| September, 2029 | $12.07 | $11.22 | $12.07 | +215.96% |
| October, 2029 | $13.40 | $12.07 | $13.13 | +250.89% |
| November, 2029 | $12.56 | $13.10 | $12.52 | +228.76% |
| December, 2029 | $12.71 | $12.76 | $12.64 | +232.80% |
Genenta Science Spa Adr Stock (GNTA) Price Forecast for 2030
Genenta Science Spa Adr Stock (GNTA) is expected to reach an average price of $10.17 in 2030, with a high forecast of $12.76 and a low forecast of $7.5817. This signifies an +166.26% surge from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.01 | $13.00 | $12.76 | +214.30% |
| February, 2030 | $11.05 | $10.73 | $10.73 | +189.15% |
| March, 2030 | $10.52 | $11.11 | $10.52 | +175.43% |
| April, 2030 | $10.86 | $10.94 | $10.79 | +184.29% |
| May, 2030 | $11.00 | $10.93 | $11.00 | +188.03% |
| June, 2030 | $11.66 | $11.92 | $11.17 | +205.17% |
| July, 2030 | $11.47 | $11.66 | $11.32 | +200.33% |
| August, 2030 | $11.02 | $11.26 | $11.33 | +188.55% |
| September, 2030 | $9.6497 | $10.30 | $10.35 | +152.61% |
| October, 2030 | $8.2426 | $8.8926 | $9.3581 | +115.78% |
| November, 2030 | $8.3372 | $8.3372 | $8.3899 | +118.25% |
| December, 2030 | $7.3817 | $7.5817 | $7.5158 | +93.24% |
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):